Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05603273 · ClinicalTrials.gov registry record · NA

Non-weight Bearing Exercise for Accelerated Healing of Diabetic Foot Ulcers

A NA study of Type 2 Diabetes and Foot Ulcer, sponsored by University of Michigan.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05603273: Recruiting NA study of Type 2 Diabetes and Foot Ulcer, sponsored by University of Michigan.

NCT05603273 is a NA study of Type 2 Diabetes and Foot Ulcer that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 40 participants, below the 3,924-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05603273, a NA study of Type 2 Diabetes and Foot Ulcer, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to improve the therapeutic management of diabetic foot ulcers (DFU). The main questions to answer are if a program of non-weight bearing exercise helps the DFU heal faster than standard wound care. This randomized clinical trial will determine how blood flow to the ulcer and whole body metabolism may be improved with exercise. Participants will be randomized to either exercise + standard wound care or standard wound care alone and undergo testing for leg blood flow, fitness and measures of metabolism through blood draws. The intervention period is 6-weeks. Eligible participants must have an existing foot ulcer uncomplicated by infection and be medically cleared to exercise.

Primary Outcome

wound site and depth

Interventions

  • BEHAVIORAL non-weight bearing exercise

Study Locations (1)

Michigan

  • School of Kinesiology - Ann Arbor

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-12-13
Est. Completion 2026-06-30
Phase NA
University of Michigan

1,327 total trials

What NCT05603273 shows while recruiting

NCT05603273 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 3,924-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which non-weight bearing exercise is the first listed.

NCT05603273 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT05603273 about?

NCT05603273 is a clinical study titled "Non-weight Bearing Exercise for Accelerated Healing of Diabetic Foot Ulcers". The goal of this study is to improve the therapeutic management of diabetic foot ulcers (DFU). The main questions to answer are if a program of non-weight bearing exercise helps the DFU heal faster than standard wound care. This randomized clinical trial will determine how blood flow to the ulcer an...

What is the current status of trial NCT05603273?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-12-13. Estimated completion is 2026-06-30.

What conditions does trial NCT05603273 study?

This clinical trial studies the following conditions: Type 2 Diabetes, Foot Ulcer.

What interventions are being tested in trial NCT05603273?

The interventions under investigation include: non-weight bearing exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT05603273?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05603273 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05603273's enrollment target sits among peer trials

40 231st of 327 higher than 88 of 327 other Type 2 Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Type 2 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05603273, the US trial registry maintained by the National Library of Medicine. NCT05603273 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.